Letter to editor: Comment on "Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation"
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.NOTCH pathway activation in adenoid cystic carcinoma (ACC) is linked to poorer survival outcomes, especially after recurrence. This highlights potential for targeted NOTCH inhibitor therapies in personalized ACC treatment strategies.
Area Of Science
- Oncology
- Molecular Biology
Background
- Adenoid cystic carcinoma (ACC) is a rare but aggressive cancer.
- Prognostic markers are crucial for guiding treatment decisions in ACC.
- The NOTCH signaling pathway plays a role in various cancers.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.